Adalimumab Biosimilar Gets FDA Approval for Rheumatic Diseases
The FDA has approved Hulio® (adalimumab-fkjp; Mylan), a biosimilar to Humira® (adalimumab; AbbVie).
Ankylosing spondylitis
Rheumatoid Arthritis and Ankylosing Spondylitis Increase Acute Mental Health Service Use
Researchers evaluated the use of acute mental health services after a diagnosis of rheumatoid arthritis or ankylosing spondylitis.
Increased Risk for Inflammatory Arthritis in Patients With Newly Diagnosed Hidradenitis Suppurativa
Researchers assessed risk for inflammatory arthritis in patients with newly diagnosed hidradenitis suppurativa.
Secukinumab Approved for Nonradiographic Axial Spondyloarthritis
The FDA has approved Cosentyx® for the treatment of adults with active nonradiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation.
Ixekizumab Approved for the Treament of Nonradiographic Axial Spondyloarthritis
The FDA has approved Taltz for the treatment of active nonradiographic axial spondyloarthritis in patients with objective signs of inflammation.
Elevated Risk for Aortic Valve Regurgitation in Ankylosing Spondylitis
Patients with ankylosing spondylitis were found to be at an elevated risk of developing aortic valve regurgitation.
Integrated Analysis Shows Long-Term Safety, Tolerability of Ixekizumab in Psoriasis, PsA, and axSpA
Researchers evaluated the long-term safety and tolerability of ixekizumab in adults with psoriasis, psoriatic arthritis and axial spondyloarthritis.
Wearable Sensor Technology Displays High Validity, Reliability as Spinal Mobility Metric in Axial Spondyloarthritis
Researchers evaluated the validity and reliability of inertial measurement unit sensors in spinal mobility assessment in axial spondyloarthritis.
Low Trabecular Bone Score Associated With New Bone Formation Independent of Fat Metaplasia in Ankylosing Spondylitis
Researchers evaluated the association between trabecular bone score and new bone formation in ankylosing spondylitis.
Fewer Patients in the Real-World vs Clinical Trials May Achieve Satisfactory Response to TNFis in axSpA
Researchers investigated the treatment response of patients receiving tumor necrosis factor inhibitors in the real-world vs clinical trials.
-
Loading...
-
Loading...
Next post in Spondyloarthritis
